華夏視聽教育(01981.HK)2021年經調整純利達1.87億元 派息率高達243%
格隆匯4月1日丨華夏視聽教育(01981.HK)公佈2021年度業績,期內集團實現來自持續經營業務收入5.78億元人民幣(單位下同),其中來自高等教育(傳媒及藝術)及職業教育的收入為4.73億元,同比增長30.4%;年內利潤為7182.2萬元,公司擁有人應占利潤為5752.7萬元,經調整純利為1.87億元;每股基本盈利為0.04元,宣派末期股息每股0.03港元及特別股息每股0.03港元,連同中期股息每股0.06港元,全年合共派息每股0.12港元,派息率高達243%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.